Valuation: AVINGER

Market Cap 2.71M 2.37M 2.19M 2.03M 3.84M 257M 3.91M 26.24M 10.2M 127M 10.16M 9.94M 439M P/E 2022
-0.25x
P/E 2023 -0.19x
Enterprise Value 12.83M 11.25M 10.36M 9.6M 18.21M 1.22B 18.53M 124M 48.31M 601M 48.16M 47.11M 2.08B EV / Sales 2022
1.19x
EV / Sales 2023 1.78x
Free-Float
88.44%
Yield 2022 *
-
Yield 2023 -
Manager TitleAgeSince
Chief Executive Officer - -
Chief Tech/Sci/R&D Officer - 2024-08-04
Change 5-day change 1-year change 3-year change Capi.($)
-2.76%+1.73%-17.89%-27.19% 12.88B
+2.94%+1.54%+87.63%+10.36% 4.81B
-2.01%+4.90%+69.84%+114.88% 1.31B
-4.95%+1.80%-34.31%-63.42% 1.24B
-3.17%+0.48%-39.79%-48.51% 1.11B
-3.85%-1.06%-46.04% - 916M
-6.68%-9.58%+158.67%+143.84% 662M
-14.22%-25.20%+35.32% - 330M
-1.87%-2.90%-55.17%+209.67% 257M
Average -4.06%-2.90%+17.58%+48.52% 2.61B
Weighted average by Cap. -1.99%-1.93%+10.89%-6.00%

Financials

2022 2023
Net sales 8.27M 7.25M 6.68M 6.19M 11.74M 786M 11.95M 80.18M 31.16M 387M 31.06M 30.39M 1.34B 7.65M 6.71M 6.18M 5.73M 10.86M 727M 11.05M 74.16M 28.82M 358M 28.73M 28.1M 1.24B
Net income -17.62M -15.45M -14.24M -13.19M -25.02M -1.67B -25.46M -171M -66.37M -825M -66.16M -64.73M -2.86B -18.32M -16.06M -14.8M -13.71M -26.01M -1.74B -26.47M -178M -69M -858M -68.78M -67.29M -2.97B
Net Debt 1.76M 1.54M 1.42M 1.31M 2.49M 167M 2.54M 17.02M 6.61M 82.24M 6.59M 6.45M 285M 10.12M 8.87M 8.18M 7.58M 14.37M 961M 14.62M 98.08M 38.11M 474M 37.99M 37.17M 1.64B
Logo AVINGER
Avinger Inc is a United States-based company. The Company operates as a medical device company that designs, manufactures, and sells image-guided, catheter-based systems for treating peripheral artery disease (PAD). Its products are used by interventional cardiologists, vascular surgeons, and interventional radiologists in the United States and select international markets and are based on its Lumivascular platform, a system that uses optical coherence tomography (OCT) for real-time visualization inside arteries. Its products includes the Lightbox imaging console, Ocelot and Tigereye catheters for crossing blockages, and Pantheris for removing plaque.
Employees
-